ANI PHARMACEUTICALS, INC Amortization of Debt Issuance Costs and Discounts
ANI PHARMACEUTICALS, INC (ANIP) reported Amortization of Debt Issuance Costs and Discounts of $715.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $357.00K, a 4.69% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $358.00K, a 10.49% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $351.00K, a 8.67% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $340.00K, a 180.99% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for fiscal 2025 was $1.36M, a 111.21% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for fiscal 2024 was $642.00K, a 83.63% decline from fiscal 2023.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for fiscal 2023 was $3.92M, a 0.98% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs and discounts for fiscal 2022 was $3.96M, a 57.68% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $715.00K 10-Q · filed 2026-08-07 | $1.07M derived: sum of 3 quarters · filed 2026-08-07 | $1.41M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $358.00K 10-Q · filed 2026-05-08 | $709.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.05M derived: sum of 3 quarters · filed 2026-05-08 | $1.39M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $691.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.03M derived: sum of 3 quarters · filed 2026-08-07 | $1.36M 10-K · filed 2026-02-27 |
| 2025-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $681.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.00M 10-Q · filed 2025-11-07 | $1.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $341.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $665.00K 10-Q · filed 2026-08-07 | $988.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $324.00K 10-Q · filed 2026-05-08 | $647.00K derived: sum of 2 quarters · filed 2026-05-08 | $768.00K derived: sum of 3 quarters · filed 2026-05-08 | $864.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $444.00K derived: sum of 2 quarters · filed 2026-02-27 | $540.00K derived: sum of 3 quarters · filed 2026-02-27 | $642.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $217.00K derived: sum of 2 quarters · filed 2025-11-07 | $319.00K 10-Q · filed 2025-11-07 | $1.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $198.00K 10-Q · filed 2025-08-08 | $1.15M derived: sum of 3 quarters · filed 2026-02-27 | $2.15M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $102.00K 10-Q · filed 2025-05-09 | $1.05M derived: sum of 2 quarters · filed 2026-02-27 | $2.05M derived: sum of 3 quarters · filed 2026-02-27 | $3.04M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $952.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.95M derived: sum of 2 quarters · filed 2026-02-27 | $2.94M derived: sum of 3 quarters · filed 2026-02-27 | $3.92M 10-K · filed 2026-02-27 |
| 2023-09-30 | $997.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.98M derived: sum of 2 quarters · filed 2024-11-08 | $2.97M 10-Q · filed 2024-11-08 | $3.97M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.97M 10-Q · filed 2024-08-06 | $2.97M derived: sum of 3 quarters · filed 2025-02-28 | $3.96M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $987.00K 10-Q · filed 2024-05-10 | $1.99M derived: sum of 2 quarters · filed 2025-02-28 | $2.98M derived: sum of 3 quarters · filed 2025-02-28 | $3.97M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $998.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.99M derived: sum of 2 quarters · filed 2025-02-28 | $2.98M derived: sum of 3 quarters · filed 2025-02-28 | $3.96M 10-K · filed 2025-02-28 |
| 2022-09-30 | $994.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.98M derived: sum of 2 quarters · filed 2023-11-08 | $2.96M 10-Q · filed 2023-11-08 | $3.76M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $987.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.97M 10-Q · filed 2023-08-09 | $2.76M derived: sum of 3 quarters · filed 2024-02-29 | $3.34M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $982.00K 10-Q · filed 2023-05-08 | $1.78M derived: sum of 2 quarters · filed 2024-02-29 | $2.35M derived: sum of 3 quarters · filed 2024-02-29 | $2.92M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $794.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.37M derived: sum of 2 quarters · filed 2024-02-29 | $1.94M derived: sum of 3 quarters · filed 2024-02-29 | $2.51M 10-K · filed 2024-02-29 |
| 2021-09-30 | $577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.15M derived: sum of 2 quarters · filed 2022-11-09 | $1.72M 10-Q · filed 2022-11-09 | $2.31M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.14M 10-Q · filed 2022-08-08 | $1.73M derived: sum of 3 quarters · filed 2023-03-09 | $2.31M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $572.00K 10-Q · filed 2022-05-10 | $1.16M derived: sum of 2 quarters · filed 2023-03-09 | $1.74M derived: sum of 3 quarters · filed 2023-03-09 | $2.27M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.17M derived: sum of 2 quarters · filed 2023-03-09 | $1.69M derived: sum of 3 quarters · filed 2023-03-09 | $1.88M 10-K · filed 2023-03-09 |
| 2020-09-30 | $583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $1.11M derived: sum of 2 quarters · filed 2021-11-01 | $1.29M 10-Q · filed 2021-11-01 | $2.63M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $705.00K 10-Q · filed 2021-08-06 | $2.05M derived: sum of 3 quarters · filed 2022-03-15 | $3.96M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $182.00K 10-Q · filed 2021-05-07 | $1.53M derived: sum of 2 quarters · filed 2022-03-15 | $3.44M derived: sum of 3 quarters · filed 2022-03-15 | $5.33M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.26M derived: sum of 2 quarters · filed 2022-03-15 | $5.15M derived: sum of 3 quarters · filed 2022-03-15 | $7.02M 10-K · filed 2022-03-15 |
| 2019-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.81M derived: sum of 2 quarters · filed 2020-11-05 | $5.68M 10-Q · filed 2020-11-05 | $7.75M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.77M 10-Q · filed 2020-08-06 | $5.84M derived: sum of 3 quarters · filed 2021-03-11 | $7.99M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $1.87M 10-Q · filed 2020-05-07 | $3.95M derived: sum of 2 quarters · filed 2021-03-11 | $6.10M derived: sum of 3 quarters · filed 2021-03-11 | $8.23M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.23M derived: sum of 2 quarters · filed 2021-03-11 | $6.36M derived: sum of 3 quarters · filed 2021-03-11 | $8.46M 10-K · filed 2021-03-11 |
| 2018-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $4.29M derived: sum of 2 quarters · filed 2019-11-06 | $6.39M 10-Q · filed 2019-11-06 | $8.34M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $4.24M 10-Q · filed 2019-08-07 | $6.18M derived: sum of 3 quarters · filed 2020-02-27 | $8.11M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $2.11M 10-Q · filed 2019-05-09 | $4.05M derived: sum of 2 quarters · filed 2020-02-27 | $5.98M derived: sum of 3 quarters · filed 2020-02-27 | $7.89M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.88M derived: sum of 2 quarters · filed 2020-02-27 | $5.78M derived: sum of 3 quarters · filed 2020-02-27 | $7.67M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $3.84M derived: sum of 2 quarters · filed 2018-11-06 | $5.72M 10-Q · filed 2018-11-06 | $7.58M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.79M 10-Q · filed 2018-08-07 | $5.65M derived: sum of 3 quarters · filed 2019-02-27 | $7.59M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.88M 10-Q · filed 2018-05-08 | $3.74M derived: sum of 2 quarters · filed 2019-02-27 | $5.68M derived: sum of 3 quarters · filed 2019-02-27 | $7.44M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $3.80M derived: sum of 2 quarters · filed 2019-02-27 | $5.56M derived: sum of 3 quarters · filed 2019-02-27 | $7.28M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $3.70M derived: sum of 2 quarters · filed 2017-11-02 | $5.42M 10-Q · filed 2017-11-02 | $7.12M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $3.48M 10-Q · filed 2017-08-03 | $5.18M derived: sum of 3 quarters · filed 2018-02-27 | $6.92M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.73M 10-Q · filed 2017-05-04 | $3.42M derived: sum of 2 quarters · filed 2018-02-27 | $5.17M derived: sum of 3 quarters · filed 2018-02-27 | $6.87M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.44M derived: sum of 2 quarters · filed 2018-02-27 | $5.15M derived: sum of 3 quarters · filed 2018-02-27 | $6.83M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.45M derived: sum of 2 quarters · filed 2016-11-03 | $5.13M 10-Q · filed 2016-11-03 | $5.69M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.39M 10-Q · filed 2016-08-04 | $3.95M derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $1.68M 10-Q · filed 2016-05-05 | $2.24M derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $559.00K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-03 | |||
| 2013-12-31 | $217.00K 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |